Fenofibrate 145 mg Tablets

Fenofibrate 145 mg Tablets
Product Description

Fenofibrate Ethypharm 145 mg is a lipid-lowering medication designed to support the management of dyslipidaemia and reduce cardiovascular risk. It is indicated as an adjunct to diet and lifestyle modifications for the treatment of severe hypertriglyceridaemia and mixed hyperlipidaemia. The formulation utilizes advanced nanoparticle technology to enhance bioavailability and ensure consistent absorption, independent of food intake. With convenient once-daily dosing and a simple administration regimen, it supports patient adherence and effective long-term management. This product can also be used in combination with statins in high-risk patients when lipid levels are not adequately controlled.

Ethypharm

  • Country/Region:
    France
  • Founded:
    1977
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Contract Service
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (innovator finished products)
Specifications
  • Details
  • Active substance: Fenofibrate
  • Pharmaceutical form: Tablets
  • Strength: 145 mg
  • Pack size: 30 tablets
  • Indications:
    • Treatment of severe hypertriglyceridaemia with or without low HDL-cholesterol
    • Mixed hyperlipidaemia when statins are contraindicated or not tolerated
    • Mixed hyperlipidaemia in high cardiovascular risk patients in combination with statins
  • Once-daily oral administration
  • Can be taken with or without food
  • Nanoparticle technology to improve bioavailability
  • Selling Points
    Cardiovascular Health;
  • Effective management of triglycerides and cholesterol levels
  • Proven reduction of cardiovascular risk factors
  • Once-daily dosing for improved convenience
  • No food restrictions (flexible administration)
  • Enhanced bioavailability with nanoparticle formulation
  • Suitable for combination therapy with statins
  • Supports long-term patient adherence
  • Model
    Fenofibrate 145 mg
  • Supplied from
    France
  • Measured In
    milligram
  • Sales Markets

    Ethypharm

    • Country/Region:
      France
    • Founded:
      1977
    • On CPHI since:
      2015
    • Certificates:
      4
    • Employees:
      1000 - 4999
    Company types
    Contract Service
    Distributor/Import Export
    Manufacturer/Innovator
    Pharmaceutical company
    Primary activities
    Contract Manufacturer
    Pharmaceutical Company (innovator finished products)

    More Products from Ethypharm (11)

    • Argatroban Solution for Infusion

      Product Argatroban Solution for Infusion

      Argatroban is a direct thrombin inhibitor used for anticoagulation in patients with heparin-induced thrombocytopenia type II (HIT II). It is administered by continuous IV infusion and offers rapid, predictable anticoagulant effects. Available as a ready-to-use solution or a concentrate for dilution, it pro...
    • Buprenorphine / Naloxone Sublingual Tablets

      Product Buprenorphine / Naloxone Sublingual Tablets

      Buprenorphine/Naloxone Sublingual Tablets are indicated for the treatment of opioid dependence as part of a comprehensive medical, social, and psychological support program. The combination of buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, is designed to reduce withdrawal symp...
    • Buprenorphine Oral Lyophilisate

      Product Buprenorphine Oral Lyophilisate

      Buprenorphine Oral Lyophilisate is a rapidly dispersing formulation designed for the treatment of opioid dependence as part of a comprehensive care program including medical, social, and psychological support. The product contains buprenorphine, a partial opioid agonist that helps reduce withdrawal symptom...
    • CDMO Capabilities

      Product CDMO Capabilities

      A wide range of dosage forms & packagings

      1. INJECTABLES 
      2. DRY FORMS 
      3. ORAL SOLUTIONS
    • Clobazam Oral Suspension

      Product Clobazam Oral Suspension

      Clobazam Oral Suspension is a benzodiazepine indicated as adjunctive therapy in epilepsy when standard treatments are insufficient. It offers flexible dosing and is suitable for patients who require a liquid formulation, including paediatric populations. Available in two strengths and multiple bottle sizes...
    • Esomeprazole Gastro-resistant Capsules

      Product Esomeprazole Gastro-resistant Capsules

      Ventra® is an esomeprazole-based gastro-resistant capsule designed for effective acid management and long-lasting gastric protection. Available in 20 mg and 40 mg strengths, it utilizes advanced microgranule technology to ensure controlled and sustained drug release, improving absorption and reducing varia...
    • Levobupivacaine Solution for Injection/Infusion

      Product Levobupivacaine Solution for Injection/Infusion

      Levobupivacaine is a long-acting local anaesthetic used for regional anaesthesia and pain management. It provides effective anaesthesia and analgesia across a wide range of clinical settings, including surgery and labour. With a similar efficacy profile to bupivacaine but lower cardiovascular and CNS toxic...
    • Morphine Sulphate Oral Solution

      Product Morphine Sulphate Oral Solution

      Morphine Sulphate Oral Solution 10 mg/5 mL is a clear liquid formulation indicated for the relief of severe pain. Containing morphine sulfate pentahydrate, it is designed for oral administration and provides reliable and flexible dosing for both adult and paediatric patients when prescribed appropriately. ...
    • Ampoules

      Product Ampoules

      Ethypharm has 2 sites for sterile ampoules manufacturing
    • Pellets in Capsules

      Product Pellets in Capsules

      Ethypharm has a strong expertise in manufacturing capsules containing modified release pellets
    • Adrenaline (Epinephrine) Solution for Injection

      Product Adrenaline (Epinephrine) Solution for Injection

      Adrenaline Solution for Injection is a fast-acting emergency medicine used for the treatment of life-threatening conditions such as anaphylaxis and cardiac arrest. It contains epinephrine, a potent sympathomimetic agent that stimulates alpha and beta-adrenergic receptors, resulting in rapid vasoconstrictio...